Disclosure: This article may contain affiliate links. If you click a link and make a purchase, we may receive a commission at no additional cost to you. All opinions remain our own.

Testosterone deficiency is one of the most common — and most underdiagnosed — endocrine complications of chronic kidney disease. Published data indicates that 40% to 60% of men on hemodialysis meet clinical criteria for hypogonadism, with prevalence increasing as renal function declines across CKD stages. Even among men with earlier-stage CKD not yet requiring dialysis, testosterone levels are consistently lower than those observed in the general population.
This is not a minor quality-of-life concern. Research published in the American Journal of Kidney Diseases, Nephrology Dialysis Transplantation, and the World Journal of Men's Health has established that low testosterone in CKD patients is independently associated with increased cardiovascular events, accelerated muscle wasting, erythropoiesis-stimulating agent (ESA) hyporesponsiveness, decreased bone mineral density, and increased all-cause mortality.
At KidneyDiseaseMS.com, our nephrology education team recognizes that testosterone management in the CKD population presents unique challenges that general men's health guidance fails to address. Standard testosterone replacement therapy (TRT) — while potentially beneficial — carries risks that are amplified in kidney disease, including fluid retention, worsening hypertension, and possible acceleration of renal disease progression through testosterone-mediated pathways affecting renal tubular integrity.
This guide examines the relationship between kidney disease and testosterone deficiency, explores why natural supportive approaches may be especially relevant for CKD patients, evaluates evidence-based ingredients that have been studied for testosterone support, and reviews natural TRT alternatives that may complement — though not replace — comprehensive nephrology care.
Important medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Men with chronic kidney disease should never begin testosterone supplementation — whether pharmaceutical or natural — without consulting their nephrologist and, ideally, an endocrinologist experienced in CKD-related hormonal disorders. Testosterone management in kidney disease requires monitoring of fluid status, blood pressure, hematocrit, PSA, and renal function markers. Many common CKD medications — including ACE inhibitors, ARBs, statins, spironolactone, and certain calcimimetics — can independently affect testosterone levels, making professional oversight essential. None of the supplements discussed in this article are manufactured in an FDA-registered facility and follows Good Manufacturing Practice (GMP) standards treatments for hypogonadism or chronic kidney disease.
Why Kidney Disease Causes Testosterone Deficiency
Understanding the mechanisms behind CKD-related testosterone decline is essential for making informed decisions about management. The uremic environment created by declining kidney function disrupts the hypothalamic-pituitary-gonadal (HPG) axis through multiple pathways simultaneously.
HPG axis dysfunction: The kidneys play a role in clearing uremic toxins that, when accumulated, impair the pulsatile secretion of gonadotropin-releasing hormone (GnRH) from the hypothalamus. This disrupts the downstream signaling cascade — reduced GnRH means reduced luteinizing hormone (LH), which means reduced testicular testosterone production. Studies in hemodialysis patients have demonstrated both primary hypogonadism (Leydig cell dysfunction) and secondary hypogonadism (impaired hypothalamic-pituitary signaling) occurring concurrently.
Chronic inflammation: CKD is characterized by persistent low-grade inflammation, with elevated interleukin-6 (IL-6) and C-reactive protein (CRP). These inflammatory mediators directly suppress testosterone production and are independently correlated with lower testosterone levels in published CKD cohort studies.
Medication effects: Many medications commonly prescribed in CKD management further suppress testosterone. ACE inhibitors and ARBs, while renoprotective, interfere with testosterone synthesis. Spironolactone blocks androgen receptors. Calcimimetics such as cinacalcet decrease both total and free testosterone concentrations. Glucocorticosteroids, frequently used in CKD management, reduce testosterone at both the gonadal and hypothalamic-pituitary level. Even opioid pain medications — common in the CKD population — suppress central testosterone signaling.
Nutritional deficiencies: CKD patients frequently present with deficiencies in zinc, vitamin D, and magnesium — all of which are direct cofactors in testosterone biosynthesis. Dietary restrictions necessary for renal management (particularly protein and potassium limitations) can exacerbate these nutritional gaps.
Dialysis-related factors: Hemodialysis itself may contribute to testosterone decline through acute hormonal fluctuations during treatment sessions, loss of nutrients in dialysate, and the physical stress of the procedure.
Why Standard TRT Requires Caution in Kidney Disease
Testosterone replacement therapy can improve quality of life, muscle mass, sexual function, and possibly anemia management in hypogonadal men with CKD. Published studies using testosterone enanthate injections in both hemodialysis and predialysis CKD populations have demonstrated reductions in hypogonadal symptom scores (ADAM questionnaire) from 7 to 3 points over 12 months of treatment.
However, the clinical consensus — reflected in guidance from nephrology, endocrinology, and urology societies — is that low testosterone in CKD should not be treated routinely but should be considered on an individual basis in symptomatic patients with documented deficiency, after careful risk-benefit assessment.
The specific concerns in CKD populations include fluid retention and volume overload (TRT can worsen edema and exacerbate heart failure in patients already prone to volume-sensitive complications), hypertension exacerbation (fluid retention and erythrocytosis from TRT can elevate blood pressure in a population where blood pressure control is paramount for slowing CKD progression), potential renal tubular injury (preclinical evidence suggests testosterone may activate Fas-FasL mediated apoptosis in renal tubule cells and increase oxidative stress and extracellular matrix deposition in the kidneys), erythrocytosis risk (while TRT's stimulation of erythropoiesis can benefit CKD-related anemia, excessive red blood cell production increases blood viscosity and thrombotic risk), and cardiovascular concern (CKD patients are already at markedly elevated cardiovascular risk, and a clinical trial in elderly men with chronic disease and mobility limitations was halted due to adverse cardiovascular events in the testosterone group).
These risks do not mean TRT is contraindicated in all CKD patients — but they do mean that careful patient selection, close monitoring, and frequent reassessment (with discontinuation if benefit is not observed after 3-6 months) are essential.
The Role of Natural Supportive Approaches
Given the complexities surrounding standard TRT in kidney disease, natural supportive approaches — lifestyle modifications and evidence-based supplementation — may serve as either complementary strategies alongside medical management or as initial interventions for mild-to-moderate testosterone decline.
The kidney disease community should approach these supplements with the same clinical scrutiny applied to any intervention. Not all ingredients commonly found in testosterone boosters are appropriate for CKD patients. Some may affect potassium levels, interact with renal medications, or stress already-compromised kidney function. The supplements reviewed below contain ingredients with published research relevant to testosterone support, but every ingredient should be reviewed with your nephrologist before use — particularly regarding potassium content, phosphorus load, and drug interactions specific to your medication regimen.
Natural TRT Alternatives: What Our Team Evaluated
The following supplements represent options that our education team reviewed based on ingredient evidence, manufacturing standards, and relevance to the concerns of men managing testosterone decline. We assessed each product for ingredient quality, transparency, safety profile, clinical evidence supporting key compounds, and practical considerations such as refund policies.
- Testosil — Strongest clinical evidence base
- Prime Male T-Vitamins — Best micronutrient-focused approach
- Nitric Boost Ultra — Best for cardiovascular and circulatory support
- TestoPrime — Best adaptogenic formula
- Alpha Bites ME Gummies — Best for antioxidant and nitric oxide support
Testosil — Strongest Clinical Evidence Base

- Format: Capsules (120 per bottle, 1-month supply)
- Key Ingredients: KSM-66 Ashwagandha, D-Aspartic Acid, ZMA (Zinc, Magnesium, B6), Fenugreek, Panax Ginseng, AstraGin
- Price: Starting at $59.99/bottle
- Refund Policy: Lifetime money-back guarantee
- Serving: 1-2 servings daily with water
Clinical Assessment
Testosil's formulation centers on KSM-66, a standardized ashwagandha extract with published RCT data demonstrating cortisol reductions of approximately 27.9% and measurable improvements in testosterone levels. For CKD patients, the cortisol-reduction mechanism is particularly relevant — chronic kidney disease is associated with elevated cortisol levels that further suppress the HPG axis, creating a compounding effect on testosterone decline. Addressing cortisol may help reduce one of the contributing factors to CKD-related hypogonadism.
The ZMA complex (Zinc, Magnesium, B6) provides three nutrients that are frequently deficient in the CKD population and are direct cofactors in testosterone biosynthesis. D-Aspartic Acid supports luteinizing hormone release — relevant given the documented LH signaling impairment in CKD patients. AstraGin enhances nutrient absorption, which may benefit CKD patients who often experience compromised GI absorption.
CKD-Specific Considerations
Magnesium supplementation requires monitoring in CKD patients, as the kidneys are the primary route of magnesium excretion — patients with significantly reduced GFR may accumulate magnesium. Zinc supplementation is generally well-tolerated but should be discussed with your nephrology team, particularly regarding interactions with phosphate binders or iron supplements. Ashwagandha has limited published safety data specifically in CKD populations. Manufactured in an FDA-registered, GMP-certified facility.
Prime Male T-Vitamins — Best Micronutrient-Focused Approach

- Format: Capsules (120 per bottle, 1-month supply, caffeine-free)
- Key Ingredients: Vitamin D, Zinc, Boron, B Vitamins, L-Carnitine, L-Arginine, Blueberry Extract, Pomegranate Extract, Taurine, Coenzyme Q10
- Price: Available on manufacturer website
- Refund Policy: 30-day (US), 14-day (Canada)
- Serving: 4 capsules daily, one with each meal and one in the evening
Clinical Assessment
Prime Male T-Vitamins takes a fundamentally different approach than concentrated testosterone boosters — it functions as a comprehensive men's multivitamin with testosterone-supportive nutrients. For CKD patients, this is noteworthy because nutritional deficiency correction is one of the most defensible interventions available.
Vitamin D deficiency is nearly universal in advanced CKD and is directly correlated with lower testosterone levels. Zinc deficiency is common and impairs testosterone biosynthesis. Boron has published data showing increases in free testosterone and reductions in estradiol at supplementation doses. L-Carnitine is particularly interesting for CKD — published studies specifically in hemodialysis patients have shown improvements in muscle function, fatigue, and quality of life with L-carnitine supplementation. Coenzyme Q10 supports mitochondrial energy production and has published data in CKD-related cardiovascular support. For a deeper dive, see Best At-Home Testosterone Tests for Kidney Disease: CKD Hormone Testing Guide (2026).
The third-party testing for potency and purity is a meaningful quality control measure, and the product is free of heavy metals, additives, fillers, and gelatin.
CKD-Specific Considerations
L-Arginine may affect blood pressure — this is a consideration for CKD patients on antihypertensive regimens. Vitamin D dosing in CKD requires medical guidance because CKD disrupts vitamin D metabolism (the kidneys convert 25-hydroxyvitamin D to its active 1,25-dihydroxyvitamin D form). CKD patients may require specific forms of vitamin D (calcitriol or paricalcitol) rather than standard D3 supplementation. Potassium content should be verified for patients on potassium-restricted diets.
Nitric Boost Ultra — Best for Cardiovascular and Circulatory Support

- Format: Powder (mix with 8-10oz water or beverage)
- Key Ingredients: Beet Root Powder, Horny Goat Weed (Icariin), Ginkgo Biloba, Dong Quai
- Price: Available on manufacturer website
- Refund Policy: 180-day money-back guarantee
- Serving: 1 scoop daily, preferably in the morning
Clinical Assessment
Nitric Boost Ultra addresses testosterone support through a cardiovascular and circulatory pathway — an approach that has particular relevance for CKD patients, given that cardiovascular disease is the leading cause of death in this population.
Beet root powder is a well-studied dietary nitrate source that supports nitric oxide production, improving endothelial function and blood flow. Published research has demonstrated beet root supplementation benefits for blood pressure management and exercise capacity — both relevant concerns in CKD. Icariin (from horny goat weed) has demonstrated PDE5 inhibitory activity and may support both vascular function and testosterone levels. Ginkgo Biloba supports cognitive function and cerebral blood flow — relevant given the cognitive decline observed in advanced CKD populations.
The powder format allows for easier dose adjustments and avoids the swallowing difficulties that some CKD patients experience with multiple capsule regimens.
CKD-Specific Considerations
Beet root is high in potassium — this is a critical consideration for CKD patients on potassium-restricted diets or those with hyperkalemia risk. Patients with GFR below 30 mL/min should discuss beet root supplementation with their nephrologist before use. Ginkgo Biloba can interact with anticoagulants and antiplatelet medications. Dong Quai may have estrogenic effects and can interact with blood thinners.
TestoPrime — Best Adaptogenic Formula

- Format: Capsules (4 daily, before breakfast)
- Key Ingredients: D-Aspartic Acid, Panax Ginseng, KSM-66 Ashwagandha, Fenugreek, Green Tea Extract, Pomegranate Extract, Zinc, Vitamin D, B Vitamins, Black Pepper Extract
- Price: Starting at $64.99/bottle
- Refund Policy: Lifetime money-back guarantee
- Serving: 4 capsules each morning before breakfast
Clinical Assessment
TestoPrime combines adaptogenic herbs (ashwagandha, ginseng) with testosterone-support compounds (D-AA, fenugreek, zinc, vitamin D) and antioxidant-rich extracts (green tea, pomegranate). The dual adaptogenic approach is relevant for CKD patients because chronic kidney disease represents a sustained physiological stressor that chronically elevates cortisol and suppresses the HPG axis.
Pomegranate extract has published research supporting antioxidant and cardiovascular benefits — particularly relevant given the oxidative stress burden in CKD. Green tea extract provides catechins with documented anti-inflammatory properties. Black pepper extract (piperine) enhances bioavailability of the other ingredients, potentially improving absorption efficiency in patients whose GI function may be compromised by uremia.
The product is manufactured in FDA-registered facilities, uses natural ingredients without reported habit-forming properties, and does not require a prescription.
CKD-Specific Considerations
Vitamin D supplementation in CKD requires medical supervision as noted above. Green tea extract contains moderate caffeine — discuss with your care team if caffeine intake is restricted. The 4-capsule morning dose may be challenging for patients already managing complex medication schedules. Fenugreek can affect blood sugar levels — relevant for CKD patients with concurrent diabetes, which is the leading cause of CKD.
Alpha Bites ME Gummies — Best for Antioxidant and Nitric Oxide Support

- Format: Gummies (30 per container, 1-month supply)
- Key Ingredients: Beet Root Powder, Catuaba Extract, Vitamin C, Maca, Muira Puama Extract, Green Tea Extract
- Price: Available on manufacturer website
- Refund Policy: 180-day money-back guarantee
- Serving: 1 gummy nightly before bedtime, recommended use for 3-4 months
Clinical Assessment
Alpha Bites ME Gummies approach testosterone support through an antioxidant and nitric oxide pathway that targets oxidative stress — a mechanism with specific relevance to kidney disease. Oxidative damage is a hallmark of CKD, contributing to endothelial dysfunction, cardiovascular complications, and accelerated aging of multiple organ systems.
Maca root has published research demonstrating improvements in libido and sexual function without directly altering testosterone levels — working through alternative neurochemical pathways. For CKD patients whose sexual dysfunction has multiple contributing factors beyond testosterone alone, this broader mechanism may be relevant. Vitamin C supports antioxidant defense and has published safety data in CKD populations at appropriate doses.
The gummy format requires only one unit daily, which minimizes pill burden — a practical benefit for CKD patients who often manage 10 or more daily medications.
CKD-Specific Considerations
Beet root powder presents the same potassium concern noted with Nitric Boost Ultra. Vitamin C at high doses can increase oxalate excretion, which is a consideration for patients with a history of kidney stones — though standard supplement doses are generally within safe ranges. Catuaba and Muira Puama have limited published data in CKD populations. Sugar content in gummy supplements should be considered for patients managing blood glucose.
Foundational Strategies for Testosterone Support in CKD
Supplementation should be considered one component of a comprehensive approach. The following lifestyle strategies have published evidence supporting testosterone optimization and are generally compatible with CKD management goals.
Resistance training is the single most potent natural testosterone stimulus and has additional benefits for CKD patients including preservation of lean muscle mass (combating the sarcopenia and protein-energy wasting that characterize advanced CKD), improvement in functional capacity and independence, and support for bone mineral density (addressing CKD-mineral bone disorder). Exercise prescriptions should be individualized with your nephrology and rehabilitation team, particularly for patients on dialysis.
Sleep optimization is critical because the majority of daily testosterone production occurs during sleep. CKD patients frequently experience sleep disruption from restless leg syndrome, sleep apnea, fluid shifts, and dialysis scheduling — addressing these factors may indirectly support hormonal health.
Nutritional deficiency correction is one of the most immediately actionable interventions. Testing for zinc, vitamin D, and magnesium status — and correcting documented deficiencies under medical supervision — may support testosterone production while addressing other CKD-related complications simultaneously. Note that standard vitamin D3 supplementation may be insufficient in CKD because impaired renal hydroxylation limits conversion to the active form.
Stress and cortisol management through evidence-based approaches (including mindfulness, cognitive behavioral therapy, and structured physical activity) may help reduce the cortisol-mediated suppression of testosterone that is amplified in the CKD population.
When to Discuss Prescription TRT with Your Nephrologist
Natural supportive approaches have a role in testosterone management, but they are not sufficient for all patients. If you are experiencing persistent symptoms of testosterone deficiency — significant fatigue, documented muscle wasting, bone density loss, severe sexual dysfunction, or depressed mood that does not respond to other interventions — a direct conversation with your nephrology team about formal testosterone evaluation is appropriate.
This evaluation should include at least two consecutive morning total testosterone measurements, free testosterone calculation (particularly important in CKD because SHBG alterations are common), LH and FSH levels to differentiate primary from secondary hypogonadism, and assessment of potentially reversible contributing factors (medication review, nutritional status, dialysis adequacy). If prescription TRT is initiated, close monitoring of fluid status, blood pressure, hematocrit, PSA, and renal function markers should be established, with reassessment after 3-6 months and discontinuation if clinical benefit is not observed.
Final Guidance from Our Education Team
Testosterone deficiency in chronic kidney disease is common, consequential, and undertreated. It contributes to the muscle wasting, anemia, bone disease, cardiovascular risk, and diminished quality of life that characterize the CKD experience. Understanding this connection — and knowing that management options exist — is an important step toward comprehensive kidney health.
Natural TRT alternatives may offer supportive benefits for some CKD patients, particularly through nutritional deficiency correction, cortisol management, and antioxidant support. However, they should always be used under medical supervision, with full awareness of CKD-specific interactions and monitoring requirements.
The most important step is the conversation with your nephrologist. Bring this information to your next appointment. Ask about testosterone testing. Discuss whether supportive supplementation is appropriate for your specific CKD stage, medication regimen, and clinical picture. Your hormonal health is part of your kidney health — and both deserve comprehensive attention.
This article was researched and prepared by the nephrology education team at KidneyDiseaseMS.com using published clinical literature from peer-reviewed nephrology and endocrinology journals. This content is for educational purposes only and does not constitute medical advice. Chronic kidney disease and testosterone deficiency are complex medical conditions requiring individualized professional management. Always consult your nephrologist, endocrinologist, or primary care provider before making changes to your health regimen. Last updated: February 28, 2026.
Related Articles
- Best Mushroom Gummies for Kidney Disease: Adaptogenic Suppor…
- GLP-1 Medications for Metabolic Health: Cardiovascular and K…
- Probiotic Supplements & Kidney Disease: Safety Guide 20…
- CBD Gummies Compared 2026: A Kidney-Aware Evaluation
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before starting any new supplement or health program, especially if you have existing medical conditions or take prescription medications.
Leave a Reply